Why we measure ApoB
Why ApoB can actually be a better predictor of cardiovascular health than LDL cholesterol.
A primary care membership for patients who want more. Primary Care. Nutrition. Wellness. All under one roof.
What is ApoB?
With 25% of deaths being attributed to cardiovascular health in the US, and 80% of heart health issues being preventable, it's critical to take a closer look at this artery-clogging, plaque-building protein.
ApoB (apolipoprotein B) comes in two forms, one produced in the intestines, the other in the liver. Both have a negative impact on our arteries. ApoB is found in our LDL (low-density lipoprotein), which accounts for most of the "bad kind" of cholesterol. (You'll also find it in other non-HDL lipoproteins, VLDL and IDL).
Why measure it?
With that in mind, research has shown that ApoB can actually be a better predictor of cardiovascular health than LDL cholesterol (which makes sense, because you're going straight to the source).
Though not yet widely standardized, at The Lanby, we include an ApoB test in a large portion of our lab panels. We optimally like to see an ApoB level of <90 mg/dL.
How can you lower it?
You guessed it: better diet, better lifestyle habits. Dietary action items to improve heart health include:
- Eat fewer trans and saturated fats
- Swap animal proteins for vegetable proteins (i.e., organic soy)
- Increase intake of fiber-rich foods
- Reduce intake of refined sugars (particularly fructose) and grains
If you're curious to learn more about The Lanby, book a free consult call and we'll chat about how The Lanby can be your personalized long term health and wellness partner.
Kendall is a graduate of the University of Mississippi, with a B.A. in Integrated Marketing Communications and a minor in Business Administration. She received her certificate of Nutrition Science from the Friedman School of Nutrition at Tufts University.
Chloe holds a bioengineering degree from the University of Pennsylvania. As a breast cancer survivor, her insights shape The Lanby's patient-centric approach. Leveraging her healthcare strategy background, Chloe pioneers concierge medicine, bridging gaps in primary care.
Tandice was recognized with the Health Law Award and named a Ruth Bader Ginsburg Scholar at Columbia Law School. Tandice's editorial role is enriched by her insights into patient autonomy and gene modification legalities. Passionate about bioethics, she is committed to crafting patient-centric healthcare solutions.